AI assistant
GENETIC SIGNATURES LIMITED — AGM Information 2017
Sep 14, 2017
65018_rns_2017-09-14_58b73348-91f2-4570-9ec1-4299760dfcf6.pdf
AGM Information
Open in viewerOpens in your device viewer
15 September 2017
==> picture [140 x 140] intentionally omitted <==
Markets Announcements Office ASX Limited Exchange Centre 20 Bridge Street SYDNEY NSW 2000
Genetic Signatures Limited: Date of 2017 Annual General Meeting
Genetic Signatures Limited (ASX: GSS) advises that its 2017 Annual General Meeting will be held on Tuesday 28 November 2017 at 11.00am (Sydney time).
Shareholders will be advised of further details regarding the 2017 Annual General Meeting in a separate Notice of Meeting, which will be provided to shareholders in October 2017.
For further details:
Company John Melki Chief Executive Officer [email protected] T: +61 2 9870 7580
About Genetic Signatures Limited: Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3Base™ . Genetic Signatures designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen™ brand. Genetic Signatures’ proprietary MDx 3Base™ platform technology provides high-volume hospital and pathology laboratories the ability to screen for a wide array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. Genetic Signatures’ current target markets are major hospital and pathology laboratories undertaking infectious disease screening.